Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02453659 · ClinicalTrials.gov registry record · NA
Women Engaging in Quitting Smoking Together
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02453659 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 100 participants.
The verdict
NCT02453659, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education (HE) comparison intervention, in which both groups also receive standard behavioral smoking cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking outcomes at 1-, 3-, and 6-month follow-ups.
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL Health Education (HE)
- BEHAVIORAL Distress Tolerance Treatment for Weight Concern (DT-W)
- BEHAVIORAL Smoking Cessation counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02453659
The ClinicalTrials.gov registry entry for NCT02453659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT02453659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02453659 about?
NCT02453659 is a clinical study titled "Women Engaging in Quitting Smoking Together". The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized c...
What is the current status of trial NCT02453659?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-05. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02453659?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), Health Education (HE) (BEHAVIORAL), Distress Tolerance Treatment for Weight Concern (DT-W) (BEHAVIORAL), Smoking Cessation counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02453659?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.